ArticleJAMA internal medicine2026
Changes in Inpatient and Skilled Nursing Facility Care After the Medicare 3-Day Rule Reinstatement.
Article in JAMA internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
Importance: On May 12, 2023, the Medicare program reinstated the long-standing 3-day hospitalization rule for skilled nursing facility (SNF) care after it had been waived for more than 2 years during the COVID-19 pandemic. This abrupt policy change offers a natural opportunity to assess the contemporary impact of the rule on inpatient and postacute care. Objective: To evaluate changes in inpatient length of stay, SNF utilization, spending, and short-term health outcomes among traditional Medicare beneficiaries following reinstatement of the 3-day hospitalization requirement. Design, Setting, and Participants: This retrospective cohort study of traditional Medicare beneficiaries with acute care hospitalizations included data from January and November 2023. A regression discontinuity design was used to examine changes in outcomes after the 3-day rule's reinstatement. Data were analyzed from June to November 2025. Exposures: Hospitalizations before vs on or after May 12, 2023. Main Outcomes and Measures: Primary outcomes were hospitalization for at least 3 days and SNF discharge. Secondary outcomes included 30-day rehospitalization, 30-day mortality, Medicare spending, and total SNF days. Results: This study included 332 044 unexposed hospitalizations (178 547 female patients [53.8%]; mean [SD] age, 78.3 [8.3] years) and 338 375 exposed hospitalizations (182 049 female patients [53.8%]; mean [SD] age, 78.2 [8.3] years) for traditional Medicare beneficiaries in 2023. Reinstatement of the 3-day rule was associated with a 1.13 percentage point (95% CI, 0.61-1.66; P < .001; relative change, 1.9%) increase in the likelihood of an inpatient stay lasting at least 3 days. Among patients discharged to SNFs, 3-day rule reinstatement increased the probability of an at least 3-day hospitalization by 5.57 percentage points (95% CI, 4.91-6.24; P < .001; relative change, 6.4%). No significant changes were observed in the overall probability of SNF discharge, 30-day rehospitalization, 30-day mortality, Medicare spending, or total SNF days. Subgroup analyses showed greater increases in at least 3-day stays among patients hospitalized for hip fractures and patients with dementia. Conclusions and Relevance: In this cohort study, reinstating Medicare's 3-day hospitalization requirement was associated with longer inpatient stays without decreases in SNF utilization or improvements in short-term health outcomes. These findings suggest that the policy imposes additional costs on hospitals while failing to lower Medicare spending on hospitalized patients. More generally, results raise questions regarding the value and continued relevance of a broadly applicable 3-day inpatient stay rule in the traditional Medicare program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.